These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28750609)

  • 21. The Influence of Cosmetic Concerns on Patient Preferences for Approaches to Thyroid Lobectomy: A Discrete Choice Experiment.
    Sukpanich R; Sanglestsawai S; Seib CD; Gosnell JE; Shen WT; Roman SA; Sosa JA; Duh QY; Suh I
    Thyroid; 2020 Sep; 30(9):1306-1313. PubMed ID: 32204688
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of information on preferences for treatments of metastatic renal cell carcinoma.
    Mansfield C; Srinivas S; Chen C; Hauber AB; Hariharan S; Matczak E; Sandin R
    Curr Med Res Opin; 2016 Nov; 32(11):1827-1838. PubMed ID: 27404275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.
    Ossa DF; Briggs A; McIntosh E; Cowell W; Littlewood T; Sculpher M
    Pharmacoeconomics; 2007; 25(3):223-37. PubMed ID: 17335308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
    Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
    Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.
    Morel T; Aymé S; Cassiman D; Simoens S; Morgan M; Vandebroek M
    Orphanet J Rare Dis; 2016 May; 11(1):70. PubMed ID: 27225337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
    Naci H; de Lissovoy G; Hollenbeak C; Custer B; Hofmann A; McClellan W; Gitlin M
    J Med Econ; 2012; 15(2):293-304. PubMed ID: 22115328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
    Wetmore JB; Peng Y; Monda KL; Kats AM; Kim DH; Bradbury BD; Collins AJ; Gilbertson DT
    Am J Nephrol; 2015; 41(4-5):354-61. PubMed ID: 26107376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives.
    Yuan Z; Levitan B; Burton P; Poulos C; Brett Hauber A; Berlin JA
    Curr Med Res Opin; 2014 Sep; 30(9):1733-41. PubMed ID: 24827068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of anemia in cancer patients: transfusions.
    Schrijvers D
    Oncologist; 2011; 16 Suppl 3():12-8. PubMed ID: 21930830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia.
    Fifer S; Godsell J; Opat S; Hamad N; Lasica M; Forsyth C; Morand L; Smeaton E; Winton S; Puig A; McGeachie M
    BMC Cancer; 2024 Jul; 24(1):831. PubMed ID: 38992616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
    Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
    Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferences for risks and benefits of treatment outcomes for chronic low back pain: Choice-based conjoint measure development and discrete choice experiment.
    Wilson L; Denham A; Ionova Y; O'Neill C; Greco CM; Hassett AL; Hanmer J; Shaikh S; Wolf M; Berven S; Williams D; Ma Y; Lotz J; Zheng P
    PM R; 2024 Aug; 16(8):836-847. PubMed ID: 38040670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Older adult patient preferences for the content and format of prescription medication labels - A best-worst scaling and discrete choice experiment study.
    Malhotra R; Suppiah SD; Tan YW; Sung P; Tay SSC; Tan NC; Koh GC; Chan A; Chew LST; Ozdemir S;
    Res Social Adm Pharm; 2023 Nov; 19(11):1455-1464. PubMed ID: 37507340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of red cell transfusion on hemodialysis-related hypotension.
    Sherman RA; Torres F; Cody RP
    Am J Kidney Dis; 1988 Jan; 11(1):33-5. PubMed ID: 3337097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease.
    Alexandre AF; Morga A; Thomas C; Krucien N; Tervonen T; Jiletcovici A; Marsh K
    Adv Ther; 2023 Feb; 40(2):641-657. PubMed ID: 36449257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
    Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.
    Hauber AB; Johnson FR; Grotzinger KM; Ozdemir S
    Ann Pharmacother; 2010 Mar; 44(3):479-88. PubMed ID: 20124463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.